Process for preparing derivatives of tripeptides

专利摘要:
Tripeptide derivatives of the formula in which X is selected from the group consisting of Pro and Phe Y is selected from the group consisting of O-R, and NH-R2 in which R, is selected from the group consisting of straight, branched and cyclic alkyl group with 1 -12 C atoms, and R2 is selected from the group consisting of H, straight, branched and cyclic alkyl group with 1 - 12 C atoms, and physiologically acceptable salts thereof. A process for producing said tripeptide derivatives by synthesis and purification methods which are known in the peptide chemistry. Pharamaceutical preparations comprising said tripeptide derivatives.
公开号:SU1034603A3
申请号:SU802961995
申请日:1980-08-21
公开日:1983-08-07
发明作者:Геран Клаесон Карл；Роджер Симонссон Лайф；Ариелли Сало
申请人:Аб Каби (Фирма)；
IPC主号:

专利说明:

CX) 4

The invention relates to a new method of producing new biologically active compounds, tripeptide derivatives, which can be used in medicine.
In the synthesis of peptides by mycro-use, the carbodiogdadic method and the activated Cl ethers method with the condensation of N-protected amino acids and peptide fragments followed by removal of the blocking groups with hydrofluoric acid 10: protected by an amino group of peptide chains Czl.
The purpose of the invention is to obtain new derivatives of tripeptides, possessing d-15 csh, interesting pharmacological properties.
The goal is achieved according to the method for producing derivatives of ± ripeptides of the general formula 20
NDH-Fen-Arg-U where.
X - Pro, Hair dryer}
U -, ORz,
R. - Straight or branched alkyl or cyclohexyl;
 hydrogen, cyclohexyl, unbranched or branched alkyl,
concluded that C-protected amino acid or peptide derivatives are condensed in solution in any sequence with activated esters of N-protected amino acids or with N1-protected amino acids and dicyclohexylcarbodiimide as a condensing agent for which it is followed by removal protecting groups by treating with hydrofluoric numbers and isolating the final compounds with the help of. ion exchange chromate-40 -Traffic.
Abbreviations used in the description:
 Amino acids in the absence of knowledge to the contrary, we are talking about figuration): Apr - arginine
Hairdryer - Phenylalanine
Pro - Proline
AcOH - acetic acid Boc - tert-butyloxycarbonyl Kbo - carbobenzoxy DIKI - dicyclohexylcarbodiide duph - dimethylformamide LNSO - dimethyl sulfoxide triethylamine EtOAc - ethyl sachet eOH - ethanol
NO - M-hydroxybenzotriazole MeOH - methanol OPNP-p-nitrophenoxy and - PROH - isopropyl alcohol TFA - trifluoroacetic acid technical layer-based chromatography
Thin-Layer Chromatography For the use of thin-layer chromatography, ready-to-use glass slides are used with silica gel plates (Merck Co.). The following mixtures are used as solvents (ratios are given in volumetric units:
A - n-butanol: AcOH: water (3: 2: 1 P - chloroform: MeOH (9: 1) Ra - chloroform: MeOH: AcOH (l7: 2: 3 Pag. - chloroform: MeOH: AcOH: BUT
(34: 4: U: 2)
M - n-butanol: AcOH ::: piri. din (30.)
After the end of the chromatographic separation, the glass plate is examined in the UV region (254 nm, after which it is treated with a chlorine / 0-toluidine reagent according to the known method). The final result of the chromatographic separation is the values.
Example 1 ND-Pro-Fen-Arg-1 -0-heptyl2HCl, mol. Weight 589.6,
1a; Kbo-Fen-Arg (M02) -OMe, mol. Weight; 514.5
27 g (o, 10 mol) of H-Apr (NO.i.-OMei. IHCl is dissolved in 4 t / in dimethylformamide and neutralized. When cooled, 18 ml of triztilagdan. The resulting ns1 is separated by filtration and added to the reaction 42 g (0.1 and 5 gül) of Kbo-Fen-OPNF mixture.The reaction mixture is left overnight with stirring, after which the solvent is distilled off in vacuum to obtain an oily residue, which is dissolved in 500 ml of ethyl acetate. The ethyl acetate phase is washed successively with a 2% solution of NaH (X) in water, water with a dilute solution of hydrochloric acid in water and water. After drying over sodium sulfate from a mixture of ethyl acetate was distilled off to about 200 ml volume and precipitate the product by the Introduction deniem ether. The crystalline precipitate was washed with ether and dried. In accordance with the obtained pure substance..
Yield: 37.6 g (73%) of substance 1a.
those: R.i 0.52 (P1) ib. Kbo-Fe Arg (M04.) - OH, Mol. weight L00.5.
3.1 g. C6 and mmol) 1a. dissolve in about 150 mp of methanol and add to the resulting solution 7.3 mmol (7.3 ml / l 1 M WaOH in water). After about 4 hours, the solvent is distilled off from the reaction mixture in vacuo, the residue is dissolved in a small amount of water and washed twice with ethyl acetate. The aqueous phase is acidified with nei to pH 2 and extracted with the resulting Kbo-Fe -Apr (MO, g) -one with three portions of ethyl acetate. The phase in ztilacetate is quenched with a 10% solution of sodium chloride in water, dried over sodium sulfate and the solvent is distilled off to dryness. The formation of the crystals is dried after leaching with ether. The resulting product in accordance with the data of those does not contain odomesy.
Yield: -2.8b (95%) of product Ib.
of those:, 14 (FQ)
1s. Kbo-Fen-Arg (I (0 0 1 epyl, mol. Yes L98.7.
0.60. ml of distilled SOCl (TO) add to 10 ml of Ggheptanol under conditions that exclude the ingress of moisture and when the mixture is cooled on an ice bath. After stirring the reaction, we mix for 1 hour at room temperature; 1.00 g (2.0 mmol) of things 1b are added to it, the reaction is continued for another 1 hour. its reaction mixture thickens to a white mass. This mass is diluted with ether and the crystals thus formed are filtered off. The crystalline mass is dissolved in methanol and precipitated with water (removing the resulting HCl). The crystals obtained after precipitation are filtered. In accordance with the data of TLC, pure heptyl ester is obtained.
Output: 962 mg (aO%) of substance 1c.
TLC: "g60 (el).
id Bok-D-Pro-, Fen-Arg (K02) -0-t tegpIL mol. Weight 661.8.
60U mg (1.0 mmol) of substance 1c are dissolved in 2 ml of acetic acid and 1.4 ml of 5.6 m HBr in acetic acid is added to the solution. The reaction mixture is poured into about 100 ml of dry ether and dried under vacuum over .aOH. The resulting hydroglycic acid salt and H-fen-Lrg (WOj) -and-heptyl: dissolved in 2 / ll of dimethylformamide and neutralized at low temperature () with triethylamine until the main reaction occurs. Obtained by This., NVG is filtered off. To the reaction mixture, 215 g (if mmol) of Wok-D-Pro-OH and 135 ml., 1.0 mg-yul) NO, and 250 mg (about 1 mmol) of dicyclohexylcarbodish / dda are added. The reaction is completed overnight, after which the resulting DNU is filtered off (after cooling the reaction mixture), and the solvent is distilled off in vacuo to form a oil-like residue. The oily residue is mixed with a small amount of NaHCOj solution in water and the resulting mass is dissolved in a small amount of methanol, and then chromatographed on a column filled with Sephadex LN-20 in methanol using methanol as eluent. Fraction containing
pure substance 1 (3 is dissolved in water and methanol and the solvents are distilled off in vacuo. 1c1 is precipitated as a heavy powder, which is collected by M and dried in-vacuum.
Yield: 570 mg (86) of the substance id. .
TLC: R 0.65 Pa, 0, b2 P1.
1. ND-Pro-Fen-Arg-O-heptyl2HCl, mol. 58U, 6. .
The protective group of 400 mg (0.6 ml) of the id substance is removed.
As a result of exposure to 30 g / w of hydrofluoric acid — wasps for one hour, in the presence of 0.4 ml of anisol. After distilling off the solvent in va-. The product is dissolved in 20 ml.
5 2% acetic acid in water and
rummed several times small. amounts of ether. The aqueous phase is chromatographed on a column filled with Sephadex G-15 in acetic acid using the same medium as eluent. In this case, i get a fraction containing abcoule but pure substance .-- Yield: 318 mg (sS) of product 1
5, 4 (with 0.7, 50% acetic acid).
TLC: R 0.27 (A), only one is clear.
Analysis for am1- {acid: Apr 1.00 {. Hair dryer 1.025 Pro 0.9U.
Example 2. ND-Pro-Fen-Arg-heptyl 2HCl, mol. Weight 5, 6.
2a Kbo-Fen-Arg (MO-MH-heptyl, i mol. Weight L97,7 ..
five
1.0 g (2.0 mmol) of Kbo-Fen-Arg (MO) -OH (16) and 0.27 mg (2.0 mmol; HRT., Dissolved, 0 tvi dimethylformamide, and then added to the resulting; at a solution in a bath of ice, 0.50 g (about 2.4 mmol) logexylcarbodiimide. After 1 hour, 0.33 ml (2.2 mmol) of heptylamine was added to the reaction mixture, then the reaction nozzle was left under stirring overnight and the resulting DSU was filtered off, and then the solvents were distilled off to form an oily residue. The specified oily residue is treated with water, 2% solution VIANO, water,
0 2% solution of KH5O, water, and in
Koitsu clean water. The resulting mass is crystallized from a mixture of methanol and water. According to technical data, it contains an insignificant admixture of side
five
Product with Rjf 0.54 (Pa) along with the main product for which Rr 0.58 (Pa..
.Outlet: 1.13 g (94%) Ver 2A. 2b. Bok-D-Pro-Fen-ArgCh O-Mn-hep0 til, mol. Weight 660.8.
Protection groups are removed from 1.0 g (1.67 mglol) of cetiecTBa 2a by treating with 4 ml of acetic acid and 2.8 ml of HBf according to example 5 РУ 1с. According to TLC, it follows that
hydrochloric acid and H-Fen-Lr- (m5.1.) MI-heptyl salt contains a main product smoldering R, -U, 61 (Pn), as well as a small amount of PULSE PRODUCT with R.J;
0.72 fPa). The hydrobromic acid salt is subjected to ion exchange on a column filled with ODE-25 in chloride form 15 / e in a mixture of SK}.% Ethanol and 10% water, using the same medium as eluent. The fraction containing the major main product in the form of chloride is combined in a quantity of. the amount of 496 mg (ii, Q mmol), after chbgo received; the product is dissolved in 2 ml of dimethylformamide and neutralized with 0.15 ml of triethylamine. Then. To the solution obtained in this way, to-. 215 mg (1.0 mmol); Boc-D-Pro OH, 135 mg (1.0 mmol) of NBT and, when cooled, 2LO mg (about 1.2 mmol) of dicyclohexylcarbodiimide. The reaction is continued for 20 hours, after which the reaction mixture is filtered and the solvent is distilled off. in vacuum with the formation of an oily mass, which -. tszrugo process with 2. ny solution of j aHCOi in water and pure water. The solution obtained in the Maasu was total in methanol and, chromatographed on a column sealed with Sephadex LN-20 in methanol using methanol as the eluent. From the fraction, containing the number of substances 2.1), the solvent is distilled off in vacuo and the residue is leached with water. The obtained crystalline mass of Suyat in vacuum, -.
Exit: 457 mg. (6%) substances 2b.
those: R 0,35 (fl), ..
2. ND - Pro - Fen-Lrg-MN-heptyl-2H1 MOvi. weight 588.6.
For 1,300 mg of compound 2b, the protective groups were removed and the source according to example 1 was removed.
B1; 1 run: 263 mg (98%) of product 2. (C.D, 6, acetic acid),
TLC: 0, 25 (, L), -only one ptn
Amino acid analysis: Lrg 1.00; Hairdryer 0, S7; About 0.98.
When and er 2. ND-Pro-Fen-Arg-MN, -2HS1, mol. weight- 490.5. . .
Behind. Bok-D-Pro-Fen-OMe, mol. Weight 376.4,
4.2g (ig, 5 mmol) of Boc-D-Pro-OH and 2.7 gCh2o, 0 mmol) NBT is dissolved in 50 gl of dimethyl sulfoxide and 4.4 g are added to the resulting solution with cooling and cooling ( about 21 mmol) of dicyclohexylcarbodiimide. To the reaction mixture was added a solution of 4.3 g (20.0 mmol) of H-Fe.n-OMe-HCl in 50 ml of dimethylformamide, preliminarily neutralized with cooling / addition of 2.8 ml (20.0 cmol) of tri-: ztilamine with subsequent filtration. The reaction mixture is left overnight and the resulting i is filtered off.
Dvdu The solvent is distilled off to dryness. obtaining from the reaction mixture an oily residue, which is dissolved in 300 / w of ethyl acetate. The solution in
the ethyl acetate is successively washed with a 2% aqueous solution of Ya.AHCO3,
water, 2% aqueous solution of KHSQj. and finally water., on the other hand cyitiaT over calcium sulphate .. Solution in
ethyl acetate is subjected to vacuum distillation to dryness to obtain a crystalline mass, which is treated with petroleum ether, is filtered and washed with petroleum ether. The resulting crystalline mass. dried in a vacuum .- .-. . . .Output: 5, b g (75%) of substance For. 0.53 Pl). 3b. Bok-D-Pro-Fey-pHu-mbl. weight
362.4. . .. . -. :
4.5 g (12.0 mmol) of the substance were added to 50 ml of MeOH and 15 ml of I-n- was added to the resulting solution. NaOH 5 mmol). After overrunning the reaction mixture at a batch temperature for 2-3 hours, the solvent is distilled off to dryness, and the resulting residue is dissolved in 10Q ml of water and washed twice with 50 ml of ether, after which the aqueous KHSO is acidified to pH. 3. After stirring at 0 ° C for 30 minutes, the reaction mixture forms a precipitate in it and deflects and rots with a small amount of cold water, after which cj / shat indicated precipitate in vacuum.
Yield: 3.3 g (74%) of compound 6,
T.CX:R 0, d1 (Pag). .
3c / Boc-D-Pro-Fen-L-rg (N () -NH., Mol. Weight 562.6;
0.65 g (1.8 mmol) of compound 36 and 0.26 g (l, y mmol) of NBT are dissolved in 10 ml of dimethylformamide and 0.38 g (about 1, is added to the resulting solution while peremeg Shvani and cooling 8 mg / 1 mol) of dicyclohexylcarbodiimide, a solution of 0.6 g (2 mmol) of H-Apr (NO, j,) - HH2 is added to the reaction mixture; HBg in 10 ml of dimethylformamide (which should be heated and re-cooled before neutralization), which is pre-neutralized with cooling 0.3 ml (2.2 mmol) of triztilamine, and which is then filtered. The reaction mixture was allowed to stand overnight and the resulting DNU was then filtered off. The solvent was distilled off from the reaction mixture to form an oily residue, which was dissolved in boiling ethyl acetate (100 ml. A precipitate formed upon cooling, which was washed with ethyl acetate and ether. Then the precipitate was dissolved (about 0.5 g) and dissolved. the amount of ethyl acetate and taken up successively with a 2% aqueous solution of NaHCO, water, water; H1LM with a 2% solution of KHQ04 and again with water. The solution in ethyl acetate is dried over sodium sulfate and then the solvent is removed in vacuo to dryness. : 480 mg 48%). Substances 3c. of those: R 0.73 (Pafe). 3. ND-Pro-.Phen-Lrg-MN2 -2HC1, mol. weight 490.5. in 160.0 ml (o, 28 mol) of compound 3c, the protective groups are removed as a result of interaction with 10 ml of HF at 0 ° C for 50 min in the presence of 0.3 ml of anisole. After distilling off the solvent in vacuo, the residue is grown. Thieves in about 5 ml of a mixture of 50% ethanol and 50% water; and ion exchange on a column containing OAE-2 in the form of chloride in a mixture of 50% ethanol and 50% water using the same mixture for elution. From the fraction containing compound 3, the solvent is distilled off in vacuo, the residue is dissolved in about 5 ml of methanol and chromium. The solution is recorded on a column of methanol with Safddex LN-20 in methanol using methanol as a medium for elution. Fraction, . containing compound 3, csraaT with 3-mirage “AI. Intake: 100 mg (71%). compound 3; tot3 |. 4-12.1 (C 0.5, methanol /, TLC: R..g 0.34 (. M j, only one, spot. Analysis of adano acids: Apr 100, Hair dryer 1.01; PRO ... .. Example: N-D-Prol; Fen-Arg-O-i-prop. 5G 2HC1, mol. Weight 533.5. -– .4. H-ArgL C) -o-and -propyl2HCl, 1 "el.ves 297.8 .. (25 gful).) is dissolved in 250 ml of isoprpranol and produced by esterification of re-processed dry gaseous HC1, according to known methods. When the reaction is complete, all volatile components are removed from the reaction mixture from dry to vacuum. The resulting ester (4a) is crystallized by dissolving the mass obtained after. distilling off the solvent — in a small amount of hot propyl alcohol and precipitated by adding dry ether while cooling the solids. The separated crystals are washed three times with dry ether. Yield: 5.8 g) of compound 4a. . So pl .: 179 - 181С. -. .. Bok-D-Pro-Fen-Arg (-O-and-propyl, mol. Weight- 605.7. Method, reagents and their amounts are completely similar to those used in Example 3c, but instead H-Aprl .NOa.) - Nir HBg using 0.60 g (2.0 mmol). compounds 4a. Yield: 440 mg U0%) of compound 46 of those: Rj 0.41 PI., .4. ND-Pro-Fen-Arg-O-and-propyl, mol. Weight 533.5. In ZiO mg (0.50 mmb of the compound: 4b, removal of the protective groups is carried out as a result of HPA-in, the presence of anisole according to method 1. The product is purified and reacted with an ion-exchange resin, similarly to method 1. Gd: 180 mg (68%) of compound 4 ., 9 (C 0.5-50.% - and acetic acid.) Those: RJ 0.21 (A), only ONE spot. Analysis of amino acids. Apr 1.0 (G, Phen 1.00 P. ro 0.98. Example 5. ND-Fen-Fvn-Arg-NH j -2Heij mol. weight 5.40,5 .. 5a. Kbo-D-Fen Fen-OMe, mol. weight 460, .5 .. The method, the reagents and their amounts are completely analogous to those used in the example. However, in Boc-D-Pro-OH used 6.0 g (; 20 mmol) Kbo-D-Phen-On. Yield: 6.2 Db7%). Compounds .5a. Those: R 0.60. (PlJ. iSb Kbo-D-Fen-Fen-OH, mol. Weight 446, 5. 6.0 g (13.0 NU) of compound 5a are hydrolyzed with NaOH according to method 36. Yield; 4-, 9., g (84%) Compounds of ss ... those: RC 0.85 (Pa). 5c. K & D-Fen-Fen-Lrg (MOg) -HH, j, mol. weight 646/7., process, reagents and their amounts completely similar to those used in Example 3c, except that the compound is used instead of compound 31h. 5b in the amount of 0.98 g 42.0 mol). Yield: 505 mg (39%) of compound 5c of those: Rj 0.80 (.Pa). 5. NDF-Fen-Arg - “% :, 2He1, mol. Weight 540.5. - For 400 mg (0.62 mmol) of compound 5c, the protective rpyrtn was cleaned and treated with an ion exchange resin according to Example 1. Yield: 296 g (88%) of compound 1., 4. (ea, 5,, methanol). , those: R 0,37 (.M), only ONE spot. Analysis of amino acids: Apr 1,0o; Hair dryer 1.97. Example 6. ND-Fen-Fen-Arg-Nn-heptyl-2He1 /. mol.ves 638.7. 6a. Kbo-D-Fen-Fen-Arg (К10,2.) - NH-rentil, mol. Weight 744.9. Methods, reagents and their amounts are completely analogous to those. used in 2b except that Kbo-D-Fen-OH is used instead of Bok-D-Pro-OH. Yield: 470 mg (b3%) of compound 6a. those: R.-0.42 (Pi). . 6. ND-Fen-Fen-Arg-UN-teptil 2He1, ol.ves 638, /. For 300 g (o, 40 mmol) of compound 6a, the protective groups are removed. purifying and treating with an ion exchange resin according to Example 1. Yield: 1/6 M-G (59%) of the compound (C 0.5, L0% acetic acid, acid). Those: 0.2V (A), only one point. Amino acid analysis: Lrg 1.00; Hair dryer 1, V8. Example 7, ND-Pro-Fen-Lrg-wh-laurilv2HCl, mol. Weight 658.7. 7. Kbo-Fen-Arg {M02,) - H-lauryl, mol. Weight 667.8. The method, the reagents and their amount are completely similar to those used in Example 2a, except that instead of heptylamine, 0.51 g (2.2 hulip) of laurylamine is used as atc. Output: 1.17 g (88%) of compound 7a TCX: R 0.60 Pa); homogeneous chromogram. (7b.bok-D-Prr-Fen-Arg (L01) - H 1-lauryl, mol. Weight. 7 30, 9. The method, reagents and their number are similar to those used in Example 2b, except that instead of 1.67 mmol of substance 2b instead of 1.67 g / 1MOL of substance 2a used in example 26, 0, L7 g (1.0 1®-1 mol) of substance 7a were used as the starting peptide. In addition, salt HBg and H-Fen-ArgNOI.) -NH-lauryl can be used without further purification using ion exchange resin. Yield: 5-5 mg (80%) of the substance. of those: Pv 0.39 IPl). 7. ND-Pro-Fen-Lrg H-lauryl-2He1 mol. Weight 65a, 7. For ZOi and mg (0.41 mmol) of substance 7b, the removal of puzzled groups, purification and treatment with ion exchange resin according to the method described in 1. Yield: ii30 mg (85%) of compound 7, 4 (e, 5, acetic acid ). TLC: R, 0.27 (A), only one spot. Analysis of a1U acid: Apr 1.00 Hairdryer 0.98} Pro 0.99. Example 8. Nd Fen Fen-Arg-N-propyl, mol. Weight 541.6. The method, reagents and their amounts are similar to Example 2a, except that 130 mg (2.2 mol) of isopropylate is used instead of pethylamine as the amine. Yield: 0.95 g of 188%) of Compound 8a TLC: YAR 0.51 CPaB is only one spot. 8b. Kbo-D-Fen-Fen-Arg (NOA) -Kn-and-propyl, they say, weight 688.8. The method, the reagents and their amounts are the same as in Example 6a, except that instead of the 2a compound, 0.54 g (1.0) of compound 8a is used as the correct dipeptide. , Yield: 470 mg (68%) of compound 8b. TLC: Rj - 0.38 (PI). 8. P-D-Phen-Oen-Arg-N-and-propyl 2HC1, mol. Weight 582.6. “. For 300 mg (0.44 lm) J of compound 8b, the protective groups are removed, purified and treated with an ion exchange resin according to example 1. A yield of 205 g (80%) of compound 8., 7 (with 0.5, metalol. TLC: , 23 (A), only one spot. Analysis of amino acids: Lrg 1.00, Fen 1.97., Example 9. H-D-Fen-Fen-Arg-T H-cyclohexyl-2nC1 ,, 622, 7 Method, reagents and their amounts are similar to example 2a, except that 218 mg (2.2 mmol) cyclo1; exyl11ina are used instead of heptilagdane as an amine. Output: 0.90 g t77%) of TLC compound 9a:, BS (Pa ), only one ipno. l9b. Kbo-L-Fen-Fen-Arg fwOa) - H-cyc-, log xyl, they say weight 728.8. Spospb, reagents and their amounts. analogous to example 6a, except that instead of compound 2a.0.58 g (1.0 mmol) of compound 9a ... is used as a protected dipeptide. Output: 520 mg (71%) of Compound 9b) TLC: R. 0, 49 (Pi). 9.N-D-Phen-Fen-Arg-MH-cyclohexyl i 2HCi f mol. weight 622.7. For 300 1LG 1.0.41 mmol) of compound 96, the protective groups are removed, cleaned and treated with ion-exchange resin according to example 1. Yield: 1 mg (72%) of compound 9, 2 1c 0.5, methanol of those : R 0, 28 (A). Analysis of amino acids: Apr 1.00 Fen 1.96. Biological tests of compounds were carried out. The activity of the compounds with respect to bradykinin inhibition was studied on the isolated uterus of rats. 12-15 hours before the experiment, rats were injected subcutaneously with 0.2 mg / kg diethylstilbestrol. The uterine muscles, longitudinally cut into two parts, are placed in a smooth muscle bath filled with De Zhalon buffer solution, into which carbonic gas (5% carbon dioxide, 95% oxygen) is passed for oxidation. The temperature is maintained at 35 ° C. Then, the muscle is subjected to a load to stretch it, corresponding to 0.5 g. The magnitude of the voltage is measured by a device for measuring the strength of the firm Grass 1, FT-OZS), which is associated with the recorder recorded by the recorder of the same company. Contractions are registered (cheekbones under the influence of bradykinin at a concentration of from 10 to 10 M (mol / l), after which the concentration of traditioninine is determined, causing 70% of the maximum muscle contractions (ED-70). Afterwards, inhibition of inactivity with bradykinin Tripeptide derivatives, with their concentration in the bath equal to 10, 10, 10, 10, and 10 M at the concentration of bradykinin corresponding to ED-70, according to
with respect to muscles. For each of the indicated concentrations, the corresponding tripeptide derivatives are inserted into the uterine tissue in 5. and 1U min before the introduction of bradykinin. Bradykinin inhibitory activity is expressed as the amount of time necessary for the brschchynin again to cause an initial contraction of the muscles. After each administration, bradykinin is produced by buffering the buffer solution.
The results of biological and experimental are listed in the table.
Table continuation

权利要求:
Claims (1)
[1]
METHOD FOR PRODUCING PRODUCTION-
NEW TRIPEPTIDES of the general formula
N-D-X-Fen-Arg-U, where X - Pro, Fen;
* S - 0Ri, W)
- unbranched or branched C ^ -C -; - alkyl or cyclohexyl hydrogen, cyclohexyl, unbranched or branched Ca> -. Ci2. "" Alkyl, characterized in that the C-protected amino acid derivatives or peptides are condensed in solution in any sequence with 'activated esters of L-protected amino acids or with N-protected amino acids and dicyclohexylcarbodiimide as a condensing' agent, followed by removal of the protecting groups by treatment hydrofluoric acid and the isolation of co-
—ΕΌ9Κ0Г T) S
10346U3

类似技术:

---

公开号 | 公开日 | 专利标题

---

SU1034603A3|1983-08-07|Process for preparing derivatives of tripeptides

---

US4118483A|1978-10-03|Peptides having gonadoliberin activity and process for their manufacture

---

JP2919965B2|1999-07-19|Dehydrodidemnin B

---

US4910296A|1990-03-20|Medicaments containing alpha 1 thymosin fragments and having an immunostimulant action, and fragments of alpha 1 thymosin

---

US4490291A|1984-12-25|Nonapeptide amides

---

CA1182448A|1985-02-12|Peptides and a process for their preparation

---

AU724781B2|2000-09-28|Peptide and method of obtaining it

---

CA1201710A|1986-03-11|Analgesic compounds

---

US3345354A|1967-10-03|Intermediate in the synthesis of alpha1-24 acth

---

RU2111214C1|1998-05-20|Peptides and pharmaceutical composition based on thereof

---

SE447389B|1986-11-10|NEW TRIPEPTIDES AFFECTING THE CENTRAL NERVOUS SYSTEM

---

EP0001684B1|1981-09-02|Tetrapeptides, methods for their preparation and their use in analgesic compositions

---

EP0000252B1|1982-02-03|Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides

---

AU620406B2|1992-02-20|Novel peptides suppressing the function of the immune system, pharmaceutical compositions containing them and process for preparing same

---

KR100251496B1|2000-05-01|Hexapeptide

---

US4322342A|1982-03-30|Analgesic compounds

---

SU793385A3|1980-12-30|Method of preparing polypeptide

---

EP0378432B1|1995-04-05|Novel peptides, their use to inhibit the maturation of t-lymphocytes and the activity of macrophages, and processes for their preparation

---

SU920053A1|1982-04-15|Method of producing peptides containing tyrosine sulphate

---

EP0033384B1|1984-02-15|Medicaments containing fragments of thymosin-alpha-1 with immunostimulating activity, and thymosin-alpha-1 fragments

---

FR2557114A1|1985-06-28|NOVEL DERIVATIVES OF GONADOLIBERIN, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

---

US4125606A|1978-11-14|Octapeptide useful for the treatment of diabetes

---

EP0228404B1|1989-03-01|Pentapeptides with cell growth regulatory effects and a process for the preparation thereof

---

US3801561A|1974-04-02|Derivatives of salmon thyrocalcitonin

---

EP0085963B1|1987-01-21|Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation

同族专利:

---

公开号 | 公开日

---

ATA905679A|1988-06-15|

---

WO1980000252A1|1980-02-21|

---

EP0009010A1|1980-03-19|

---

JPS55500520A|1980-08-14|

---

DK149630B|1986-08-18|

---

DK116380A|1980-03-18|

---

US4242329A|1980-12-30|

---

AT387393B|1989-01-10|

---

DK149630C|1987-01-26|

---

DE2964956D1|1983-04-07|

---

EP0009010B1|1983-03-02|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

NL6808554A|1967-06-30|1968-12-31|

---

JPS5035061B1|1970-08-07|1975-11-13|

---

JPS5010569B1|1970-08-12|1975-04-22|

---

SE380257B|1972-05-02|1975-11-03|Bofors Ab|NEW DIAGNOSTIC OPERATING SUBSTRATES WITH HIGH SPECIFICITY FOR THROMBIN AND OTHER PROTEOLYTIC ENZYMES OF THE PEPTIDYL-PEPTIDE HYDROLASES|

---

DE2527932C2|1974-07-02|1983-04-21|Pentapharm AG, 4052 Basel|Acid addition salts of tripeptide derivatives and their use as substrates for the determination of plasma kallikrein|

---

SE407571B|1975-07-11|1979-04-02|Kabi Ab|NEW CHROMOGENA ENZYME SUBSTRATE FOR SERINE PROTEASES|

---

NL7607683A|1976-07-12|1978-01-16|Akzo Nv|PROCESS FOR PREPARING NEW PEPTIDES AND PEPTIDE DERIVATIVES AND THEIR USE|DE3164437D1|1980-08-25|1984-08-02|Kabivitrum Ab|Peptide substrates for determination of protease activity|

---

US4448715A|1981-11-02|1984-05-15|University Of Miami|Tagged pyroglu-L-Phe-L-Arg derivatives, substrates and assays for kallikrein|

---

JPS62501147A|1984-12-14|1987-05-07|

---

GB8622090D0|1986-09-12|1986-10-22|Wellcome Found|Pharmacologically active compounds|

---

US5648333A|1988-11-24|1997-07-15|Hoechst Aktiengesellschaft|Peptides having bradykinin antagonist action|

---

GB9019558D0|1990-09-07|1990-10-24|Szelke Michael|Enzyme inhibitors|

---

AT169823T|1991-04-19|1998-09-15|Scios Nova Inc|BRADYKININ TYPICAL PEPTIDES|

---

US6770741B1|1991-04-19|2004-08-03|Scios Inc.|Bradykinin antagonist peptides|

---

AU1873992A|1991-04-19|1992-11-17|Nova Technology Limited Partnership|Bradykinin antagonist peptides|

---

WO1993011789A1|1991-12-12|1993-06-24|Scios Nova Inc.|Modified positionbradykinin antagonist peptides|

---

TW199863B|1991-12-21|1993-02-11|Hoechst Ag|

---

US5686565A|1992-10-08|1997-11-11|Scios Inc.|Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins|

---

US5541286A|1992-10-08|1996-07-30|Scios Nova Inc.|Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids|

---

US5521158A|1992-10-08|1996-05-28|Scios Nova Inc.|Pseudopeptide bradykinin receptor antagonists|

---

US5610142A|1992-10-08|1997-03-11|Scios Inc.|Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids|

---

US5817756A|1993-09-09|1998-10-06|Scios Inc.|Pseudo- and non-peptide bradykinin receptor antagonists|

---

IL108031D0|1992-12-22|1994-04-12|Procter & Gamble|Difluoro pentapeptide derivatives and pharmaceutical compositions containing them|

---

WO1994019372A1|1993-02-17|1994-09-01|Scios Nova Inc.|Cyclic bradykinin antagonist peptides|

---

US5510380A|1993-02-19|1996-04-23|Sterling Winthrop, Inc.|Nonpeptide bradykinin antagonists|

---

US5486623A|1993-12-08|1996-01-23|Prototek, Inc.|Cysteine protease inhibitors containing heterocyclic leaving groups|

---

JPH09511500A|1994-03-09|1997-11-18|コーテック，インコーポレイティド|Bradykinin antagonist peptide containing N-substituted glycine|

---

FR2794974B1|1999-06-16|2001-08-17|Exsymol Sa|COSMETIC COMPOSITION FOR SLIMMING BASED ON L-ARGININE, AN ANALOG OF L-ARGININE OR A DERIVATIVE THEREOF, APPLICABLE TOPICALLY|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

SE7807937|1978-07-18|

---